August 2019 Issue Table Of Contents

From The Editor

• Some Things Come From No Things

Feature Article

• How Serial Entrepreneur Robert Hariri Is Revolutionizing Cell Therapy

Capitol Perspectives

• Arbitration For Pharmaceuticals?

CEO Corner

• Strategies For Success: Developing Drugs For Orphan Diseases

From Principles and Policy to Execution

• Healthcare Debunked

Companies To Watch

• Bioharmony Therapeutics

Industry Research

• The Most Important Oral Dose Life Cycle Extension Strategies
• Improving Outsourcing Relationships

Inside The Industry

• Strategies For Patenting AI Innovations In Life Sciences
• A Second Career As A Biotech CEO
• Meeting Business Challenges By Design, Not Accident
• Data Privacy And Cybersecurity Considerations For Life Science Companies
• How To Build A Compliance Program That’s Rightsized For Your Organization
• The Importance Of Pursuing Clinical Trial Costs
• CDMO-To-Hospital: A Direct Ending For Generic Shortages?

Leadership Lessons

• A Network Cyberattack I’ll Never Forget

Ask The Board

• When Is The Best Time For A Scientist To Transition Into A Life Science Leader?
• How Do You View The Integration Of Clinical Research With Clinical Care, And What Approaches Align To Make Clinical Trials Potential Care Options?
• What Are The Most Influential Consortia?